Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ocular Therapeutix (OCUL) Operating Margin (2016 - 2025)

Historic Operating Margin for Ocular Therapeutix (OCUL) over the last 13 years, with Q4 2025 value amounting to 526.49%.

  • Ocular Therapeutix's Operating Margin fell 2304100.0% to 526.49% in Q4 2025 from the same period last year, while for Dec 2025 it was 519.75%, marking a year-over-year decrease of 2501700.0%. This contributed to the annual value of 519.75% for FY2025, which is 2501800.0% down from last year.
  • Ocular Therapeutix's Operating Margin amounted to 526.49% in Q4 2025, which was down 2304100.0% from 472.35% recorded in Q3 2025.
  • In the past 5 years, Ocular Therapeutix's Operating Margin registered a high of 127.41% during Q3 2023, and its lowest value of 597.47% during Q1 2025.
  • For the 5-year period, Ocular Therapeutix's Operating Margin averaged around 255.5%, with its median value being 176.35% (2022).
  • Per our database at Business Quant, Ocular Therapeutix's Operating Margin skyrocketed by 9671900bps in 2021 and then plummeted by -3834600bps in 2025.
  • Over the past 5 years, Ocular Therapeutix's Operating Margin (Quarter) stood at 146.64% in 2021, then rose by 6bps to 137.56% in 2022, then rose by 2bps to 135.46% in 2023, then tumbled by -119bps to 296.08% in 2024, then plummeted by -78bps to 526.49% in 2025.
  • Its last three reported values are 526.49% in Q4 2025, 472.35% for Q3 2025, and 502.57% during Q2 2025.